A HIV /AIDS case diagnosed with concomitant Pneumocystis jiroveci pneumonia and pulmonary tuberculosis confused with COVID-19 pneumonia

Abstract

Bacterial and fungal infections can be seen with COVID-19.Besides, some infectious diseases may be confused with pneumonia due to COVID-19 infection. In this article, a 60-year-old male patient who was referred to our clinic with a preliminary diagnosis of COVID-19 pneumonia and finally diagnosed with Pneumocystis jirovecii pneumonia and pulmonary tuberculosis due to HIV infection is presented. The patient's complaints of fever, cough and sputum production at the time of admission completely resolved after Pneumocystis jirovecii and pulmonary tuberculosis treatments.

Keywords

• COVID-19 pneumonia
• differential diagnosis
• HIV/AIDS
• Pneumocytis jirovecii
• Mycobacterium tuberculosis

COVID-19 pnCOVID-19 pömonisi ile karışan eş zamanlı Pneumocystis jirovecii pnömonisi ve Akciğer tüberkülozu tanısı konulan bir HIV/AIDS olgusu

Abstract

Bakteriyel ve fungal infeksiyonlar COVID-19 ile birlikte görülebilir. Ayrıca, bazı infeksiyon hastalıkları COVID-19 infeksiyonuna bağlı pnömoni ile karışabilir. Bu yazıda, COVID-19 pnömonisi ön tanısıyla kliniğimize sevkedilen, HIV infeksiyonuna bağlı Pneumocystis jiroveci pnömonisi ve akciğer tüberkülozu tanısı konulan 60 yaşında bir erkek hasta sunuldu. Hastanın başvuru esnasındaki ateş, öksürük ve balgam çıkarma yakınmaları Pneumocystis jiroveci ve akciğer tüberkülozu tedavisi sonrasında tamamen düzeldi.

Keywords

• COVID-19 pnömonisi, syırıcı tanı,
• HIV/AIDS
• ,Pneumocystis jirovecii
• Mycobacterium tuberculosis

References

1. 1. Abdoli A, Falahi S, Kenarkoohi A. COVID-19-associated opportunistic infections: a snapshot on the current reports. Clin Exp Med. 2021;1-20. doi: 10.1007/s10238-021-00751-7.
2. 2. HIV/AIDS Tanı ve Tedavi Rehberi, Halk Sağlığı Genel Müdürlüğü, Sağlık Bakanlığı Yayın No 1133,, Ankara, 2019. https://hsgm.saglik.gov.tr/depo/birimler/Bulasici-hastaliklar-db/hastaliklar/HIV-ADS/Tani-Tedavi_Rehberi/HIV_AIDS_Tani_Tedavi_Rehberi_Yeni.pdf
3. 3. Tasaka S, Tokuda H. Expert Opin. Med. Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults. Diagn. 2013; 7(1): 85-97.
4. 4. Gao Y, Liu M, Chen Y, Shi S, Geng J, and Tian J. Association between tuberculosis and COVID‐19 severity and mortality: A rapid systematic review and meta‐analysis. J Med Virol. 2020; 10.1002/jmv.26311. doi: 10.1002/jmv.26311.
5. 5. Visca D, Ong CWM, Tiberi S, Centis R, D'Ambrosio L, Chen B,et al. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology 2021; 27(2):151-165.
6. 6. Boulle A., Davies M.A., Hussey H., Ismail M., Morden E., Vundle Z. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa1198. ciaa1198.
7. 7. Liu S, Li Q, Chu X, Zeng M, Liu M, He X, Zou H, et al. Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools. Front Public Health. 2021; 9: 672215. doi: 10.3389/ fpubh.2021.672215.
8. 8. Parekh M, Donuru A, Balasubramanya R, and Kapur S. Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era. Radiology. 2020; 202504. doi: 10.1148/radiol.2020202504.